✦ LIBER ✦

Taenia solium dUTPase: A potential target for anti-human cysticercosis

✍ Scribed by Yadong Zheng; Xuenong Luo; Zhenyong Liu; Zhizhong Jing; Wanzhong Jia; Xuepeng Cai

Book ID: 116181940
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 602 KB
Volume: 101
Category: Article
ISSN: 0001-706X
DOI: 10.1016/j.actatropica.2007.02.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taenia solium cDNA sequence encoding a p

Taenia solium cDNA sequence encoding a putative immunodiagnostic antigen for human cysticercosis

✍ E. Montero; L.M. González; L.J.S. Harrison; R.M.E. Parkhouse; T. Gárate 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 845 KB

An Enzyme-Linked Immunoelectrotransfer B

An Enzyme-Linked Immunoelectrotransfer Blot Assay and Glycoprotein Antigens for Diagnosing Human Cysticercosis (Taenia solium)

✍ Tsang, V. C. W.; Brand, J. A.; Boyer, A. E. 📂 Article 📅 1989 🏛 University of Chicago Press 🌐 English ⚖ 866 KB

The receptor for human urokinase: a pote

The receptor for human urokinase: a potential target for anti-invasive and anti-metastatic therapy

✍ Maria Teresa Masucci; Francesco Blasi 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 741 KB

Generation of a monoclonal human single

Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells – a potential mechanism for targeting liver anti-fibrotic therapeutics

✍ Lucy J. Elrick; Val Leel; Morgan G. Blaylock; Linda Duncan; Matthew R. Drever; G 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 763 KB

ErbB4 increases the proliferation potent

ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy

✍ Alex Starr; Joel Greif; Akiva Vexler; Maia Ashkenazy-Voghera; Valery Gladesh; Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB 👁 1 views

## Abstract Clinical and experimental data suggest that ErbB‐4, a member of the epidermal growth factor receptor family, may have a role in cancer progression and response to treatment. We found recently, using a retrospective clinical analysis, that expression of ErbB‐4 receptor is correlated with